No Data
No Data
Yunnan Jianzhijia Health-Chain (605266.SH): A total of 0.58% of shares have been repurchased, and the repurchase period has expired.
According to the announcement on December 19 by Gelonghui, Yunnan Jianzhijia Health-Chain (605266.SH) reported that as of the date of the announcement, the share repurchase period has expired. The company has repurchased a total of 0.9034 million shares through the Shanghai Exchange via centralized bidding, accounting for 0.58% of the company’s total shares. The repurchase price ranged from 18.21 to 27.31 yuan per share, with a total amount of funds used reaching 20.4969 million yuan, which has met the lower limit of the repurchase amount for the scheme. The progress of the repurchased shares complies with relevant laws and regulations as well as the requirements of the company's share repurchase plan.
Express News | This week, more than ten listed companies announced the disclosure of repurchase, shareholding, and refinancing-related situations. The indirect controlling shareholder of Deppon Logistics intends to increase shareholding and obtain loans not exceeding 0.
Express News | Yunnan jianzhijia health-chain plans to repurchase company shares at no less than 50 million yuan and no more than 0.1 billion yuan.
yunnan jianzhijia health-chain (605266.SH): Obtain special loan support for repurchasing shares
Gelonghui November 25th | Yunnan Jianzhijia Health-Chain (605266.SH) announced that, according to the spirit of the "Notice on Establishing Relevant Matters for Stock Buyback and Shareholding Refinancing by the People's Bank of China, the China Banking and Insurance Regulatory Commission, and the China Securities Regulatory Commission", the Kunming Branch of China Construction Bank Limited has recently completed the loan approval, agreeing to provide a special loan for share buyback of up to 70 million yuan, with a loan term of 1 year. The source of funds for this share buyback is from the company's own funds and special loans for share repurchases.
Stock market midday report: the chinext price index rose by 1.78%, with over 3000 stocks increasing. The pharmaceutical commerce concept leads the gains.
As of the midday close, the Shanghai Composite Index fell by 0.06%, the Shenzhen Component Index rose by 1.02%, and the chinext price index rose by 1.78%.
Yunnan Jianzhijia Health-chain (605266): The operation improved compared to the previous period and continued to promote structural optimization.
On the evening of October 29, the company released the 2024 third-quarter performance report, achieving revenue of 6.735 billion yuan, a year-on-year increase of 3.63%, and achieving a net income attributable to the parent company of 0.101 billion yuan, a year-on-year decrease of 63.
No Data